Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Aduhelm
Aduhelm
Roche, Biogen temper Alzheimer’s expectations in Q2 calls. Will Lilly follow suit in August?
Fierce Biotech
Fri, 07/22/22 - 11:21 am
Alzheimer's disease
Roche
Biogen
Eli Lilly
lecanemab
gantenerumab
Aduhelm
For accounting purposes, Biogen says its $223M inventory of Aduhelm is basically worthless
Endpoints
Thu, 07/21/22 - 09:47 pm
Biogen
Aduhelm
Alzheimer's disease
SEC
Biogen, targeting $1B in savings, employs 300 fewer staffers in Massachusetts than it did in September: report
Fierce Biotech
Mon, 07/18/22 - 07:19 pm
Biogen
layoffs
Cambridge MA
Aduhelm
Biogen, citing insurance challenges, shutters one of its Aduhelm studies
BioPharma Dive
Wed, 06/22/22 - 06:54 pm
Biogen
real world data
Alzheimer's disease
Medicare
Aduhelm
Medicare premiums to remain unchanged after Aduhelm price cut spurs review
BioPharma Dive
Tue, 05/31/22 - 11:56 pm
Medicare
Medicare Part B
Biogen
Aduhelm
HHS
Alzheimer's disease
Survey puts spotlight on US neurologists’ response to CMS Alzheimer drugs decision
Biopharma Reporter
Mon, 05/16/22 - 10:48 am
Biogen
Aduhelm
monoclonal antibodies
CMS
Alzheimer's disease
neurologists
Biogen shoves Aduhelm to the side. It's time for lecanemab
Fierce Biotech
Wed, 05/4/22 - 10:33 am
Biogen
Aduhelm
lecanemab
Eisai
Alzheimer's disease
Vounatsos Out as Biogen Appears to Concede Defeat Over Aduhelm
BioSpace
Tue, 05/3/22 - 10:52 am
Biogen
Pharma CEOs
Aduhelm
Michel Vounatsos
Is Biogen Planning to Appeal CMS Aduhelm Reimbursement Decision?
BioSpace
Mon, 05/2/22 - 06:08 pm
Biogen
CMS
Alzheimer's disease
Aduhelm
Things Just Got Worse for Biogen
Motley Fool
Tue, 04/26/22 - 10:18 am
Biogen
Aduhelm
Alzheimer's disease
Europe
Vumerity
multiple sclerosis
digital health
Biogen pulls European application for Aduhelm in another setback for the Alzheimer's drug
BioPharma Dive
Fri, 04/22/22 - 10:49 am
Biogen
Aduhelm
Europe
Alzheimer's disease
Biogen’s head-scratching new lobbyist hire
Stat
Wed, 04/20/22 - 10:50 am
Biogen
Aduhelm
lobbyist
lobbying
The next battle in the never-ending war over Aduhelm
Stat
Fri, 04/15/22 - 01:50 pm
Biogen
Aduhelm
Medicare
CMS
Eli Lilly
Alzheimer's disease
CMS official on Alzheimer's drug coverage decision: Don't read between the lines for other accelerated approvals
Endpoints
Wed, 04/13/22 - 10:54 am
CMS
Medicare
Biogen
Aduhelm
accelerated approvals
How CMS independence is at the forefront of its Alzheimer's drug coverage decision
Endpoints
Mon, 04/11/22 - 10:34 am
CMS
Medicare
Biogen
Aduhelm
Alzheimer's disease
With Aduhelm slapped down by CMS, what's next for Biogen?
Fierce Pharma
Fri, 04/8/22 - 10:29 am
Biogen
Aduhelm
Medicare
Alzheimer's disease
CMS finalizes restrictions on Biogen's Alzheimer's drug coverage, will only fund use in clinical trials
Endpoints
Thu, 04/7/22 - 06:13 pm
Biogen
Aduhelm
CMS
Alzheimer's disease
clinical trials
Medicare
'About as true as saying the earth is flat': Alzheimer's expert picks apart Biogen's Aduhelm manuscript
Endpoints
Mon, 04/4/22 - 11:22 pm
Biogen
Aduhelm
Alzheimer's disease
Califf admits controversy over FDA’s Alzheimer’s drug decision impacted experts’ trust in the agency
Stat
Thu, 03/31/22 - 11:22 pm
Robert Califf
FDA
Biogen
Aduhelm
Biogen Submits Final Plan for Confirmatory Aduhelm Trial
BioSpace
Thu, 03/31/22 - 10:14 am
Biogen
Aduhelm
clinical trials
Alzheimer's disease
Pages
« first
‹ previous
1
2
3
4
5
6
7
8
next ›
last »